BioMimetic Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 13   

Articles published

BMTI 0.0000
price chart
( PETV ) PetVivo Announces Commercial Launch Schedule
MINNEAPOLIS, MN / ACCESSWIRE / August 19th, 2014 / PetVivo Holdings, Inc. (OTCPINK:PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is pleased to ...
Related articles »  
Chamber, YP name '14 NELA winners
In her previous role at BioMimetic Therapeutics, Patterson played an integral role in managing the communications, investor, analyst and investment bank relations activity for the company's initial public offering. She is the current president of the ...
7 healthcare and life sciences projects get love from Maryland in $6.5 million ...
EMOCHA Mobile Health, a telehealth company received $100,000. Its mobile ... Asclepix Therapeutics is developing biomimetic peptide therapies to treat eye diseases, including macular edema, with technology licensed from Johns Hopkins University.
( PETV PETV ) PetVivo Announces Expansion of Licensing & Planned Merger ...
ACCESSWIRE / PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics announced today that Gel-Del Technologies, Inc., the ...
Related articles »  
Biotech Stock Directory Update
BioMimetic Therapeutics, Inc. (NasdaqGS:BMTI) is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for ...
CN Bio Innovations Marks World Hepatitis Day by Signing Research Agreement ...
CN Bio Innovations Ltd (CN Bio) an expert in developing leading edge human biomimetic platforms to test and develop therapeutics for serious diseases announced today that it has signed a research agreement with Imperial College London to advance the ...
Related articles »  
Surge in R&D Investments to Drive the Global Biocompatible Materials Market ...
Asia-Pacific ranks as the fastest growing market with a CAGR of 18.8% over the analysis period. Major players covered in the report include AdvanSource Biomaterials Corporation, BASF Corporation, Biomet, BioMimetic Therapeutics, Celanese Corporation, ...
Related articles »